Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
CVS Health | CVS | Oct 11, 2024 | 66.63 | -0.33 |
CXApp A | CXAI | Oct 11, 2024 | 1.58 | +1.28 |
CyberArk Software | CYBR | Oct 11, 2024 | 295.30 | +0.29 |
Cybin | CYBN | Oct 11, 2024 | 9.78 | +1.45 |
Cyclacel Pharmaceuticals | CYCC | Oct 11, 2024 | 0.80 | +0.60 |
Cyclacel Pharmaceuticals Pref | CYCCP | Oct 11, 2024 | 6.81 | -9.08 |
Cyclerion Therapeutics | CYCN | Oct 11, 2024 | 2.55 | -0.23 |
Cyclo Therapeutics | CYTH | Oct 11, 2024 | 0.77 | +0.52 |
Cyngn | CYN | Oct 11, 2024 | 3.72 | +1.92 |
Cytek Biosciences | CTKB | Oct 11, 2024 | 5.01 | +2.87 |
Cytokinetics | CYTK | Oct 11, 2024 | 54.88 | +3.25 |
Cytomed Therapeutics | GDTC | Oct 11, 2024 | 2.04 | +1.49 |
CytomX Therapeutics | CTMX | Oct 11, 2024 | 1.15 | +2.68 |
Cytosorbents | CTSO | Oct 11, 2024 | 1.12 | +6.67 |
D-MARKET Electronic Services & Trading ADR | HEPS | Oct 11, 2024 | 2.24 | -0.44 |
D-Wave Quantum | QBTS | Oct 11, 2024 | 0.97 | +8.61 |
D.R. Horton | DHI | Oct 11, 2024 | 182.82 | -0.31 |
Dada Nexus ADR | DADA | Oct 11, 2024 | 1.85 | 0.00 |
Daily Journal | DJCO | Oct 11, 2024 | 468.23 | -0.06 |
Dakota Gold | DC | Oct 11, 2024 | 2.19 | 0.00 |
Daktronics | DAKT | Oct 11, 2024 | 13.52 | +3.36 |
DallasNews A | DALN | Oct 11, 2024 | 4.48 | +4.19 |
Dana | DAN | Oct 11, 2024 | 10.78 | +1.89 |
Danaher | DHR | Oct 11, 2024 | 270.33 | +1.46 |
Danaos | DAC | Oct 11, 2024 | 86.96 | -0.11 |
Danimer Scientific | DNMR | Oct 11, 2024 | 0.42 | +0.36 |
DAQO New Energy ADR | DQ | Oct 11, 2024 | 20.50 | +2.50 |
Darden Restaurants | DRI | Oct 11, 2024 | 156.72 | +0.51 |
Daré Bioscience | DARE | Oct 11, 2024 | 3.35 | +0.45 |
DarioHealth | DRIO | Oct 11, 2024 | 1.02 | 0.00 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.